SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neptune Technologies & Bioressources Inc. - NTB.V
NEPT 0.200-45.9%Mar 6 3:00 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Ox who wrote (859)8/5/2021 12:46:49 PM
From: Sultan1 Recommendation

Recommended By
The Ox

   of 902
 
Insiders

CEO, Michael Cammarata

Direct Ownership

Common Shares 3,439,136
Options 10,848,261
Restricted Share Units 855,550

Chairman of the Board, John Moretz

Direct Ownership

Common Shares 3,365,226
Options 150,000

Indirect Ownership

Common Shares 940,590

CEO has been steadily playing around with his restricted share units and have also bought on the open market at a lot of different price point..

The chairman, has from day 1 have steadily bought and accumulated a sizable stake. Without question, he has been and continues to be a big believer in the company so let's see where all of this leads.. His latest purchase was in July.. 150k shares

canadianinsider.com

Disclaimer.. I have a rather large position.. However, it is all under water at this point..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News